You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Cefepime Hydrochloride, and what generic alternatives are available?

Cefepime Hydrochloride is a drug marketed by Acs Dobfar, Astral, Fosun Pharma, Hospira Inc, Qilu, Sagent Pharms Inc, and Samson Medcl. and is included in eight NDAs.

The generic ingredient in CEFEPIME HYDROCHLORIDE is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefepime Hydrochloride

A generic version of CEFEPIME HYDROCHLORIDE was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CEFEPIME HYDROCHLORIDE?
  • What are the global sales for CEFEPIME HYDROCHLORIDE?
  • What is Average Wholesale Price for CEFEPIME HYDROCHLORIDE?
Drug patent expirations by year for CEFEPIME HYDROCHLORIDE
Recent Clinical Trials for CEFEPIME HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Meiji Seika Pharma Co., Ltd.Phase 3
Linical Co., Ltd.Phase 2
AllecraPhase 2

See all CEFEPIME HYDROCHLORIDE clinical trials


US Patents and Regulatory Information for CEFEPIME HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 065441-001 Mar 20, 2008 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Samson Medcl CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER cefepime hydrochloride POWDER;INTRAVENOUS 209408-001 Aug 21, 2018 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fosun Pharma CEFEPIME HYDROCHLORIDE cefepime hydrochloride INJECTABLE;INJECTION 090291-001 Dec 21, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.